首页> 美国卫生研究院文献>Human Vaccines Immunotherapeutics >Nizatidine a small molecular compound enhances killed H5N1 vaccine cell-mediated responses and protects mice from lethal viral challenge
【2h】

Nizatidine a small molecular compound enhances killed H5N1 vaccine cell-mediated responses and protects mice from lethal viral challenge

机译:尼扎替丁一种小分子化合物可增强被杀死的H5N1疫苗细胞介导的反应并保护小鼠免受致命的病毒攻击

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Nizatidine (NIZ), closely related to Cimetidine, is a histamine H2 receptor inverse agonist used primarily as an anti-acid drug. Recent studies showed that this class of compounds may also modulate immune responses. To evaluate adjuvant effects of NIZ on vaccine immune modulation, we formulated NIZ with a H5N1 killed viral antigen and tested in vitro and in vivo. NIZ activated DC maturation and stimulated Th1 and Th2 immune responses to H5N1 vaccine. As a result, it enhanced both antibody and T cell-mediated immune responses. We also observed that a single immunization into C57BL/6 mice blocked IL-10 upregulation and potentiated Th1/Th2 dual polarization. Importantly, the inoculation of H5N1 vaccine with NIZ significantly improved protection of animals from death after challenge and reduced virus loads in the lung tissues. Considering its water-soluble nature, compared with Cimetidine, Nizatidine may be a better choice to use as a vaccine adjuvant.
机译:与西咪替丁密切相关的尼扎替丁(NIZ)是一种组胺H2受体反向激动剂,主要用作抗酸药。最近的研究表明,这类化合物也可能调节免疫反应。为了评估NIZ对疫苗免疫调节的佐剂作用,我们将NIZ与H5N1杀死的病毒抗原一起配制,并在体内和体外进行了测试。 NIZ激活了DC成熟,并刺激了针对H5N1疫苗的Th1和Th2免疫反应。结果,它增强了抗体和T细胞介导的免疫反应。我们还观察到对C57BL / 6小鼠的单次免疫可阻止IL-10上调并增强Th1 / Th2双极化。重要的是,用NIZ接种H5N1疫苗可显着提高动物免受攻击后的保护,并减少肺组织中的病毒载量。考虑到其水溶性,与西咪替丁相比,尼扎替丁可能是用作疫苗佐剂的更好选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号